12:45 PM - 1:45 PM
[2PL1] Tofacitinib (CP-690,550): A First-In-Class Janus Kinase (JAK) Inhibitor for the Treatment of Rheumatoid Arthritis
tofacitinib, CP-690,550, Janus kinase, JAK/STAT, JAK pathways
Contents of this site has moved to the member page of The Japanese Biochemical Society: https://member.jbsoc.or.jp/mypage/
You can access the abstracts without credentials by accessing them via the member page.
You need the membership number and password to access the member page. Please contact the journal office for any inquiries.
Journal Office Contact Information: